iCo Therapeutics Inc.: iCo Therapeutics Announces First Quarter 2021 Financial Results
Vancouver, British Columbia--(Newsfile Corp. - May 31, 2021) - iCo Therapeutics (TSXV: ICO) (OTCQB: ICOTF) ("iCo" or the "Company"), today reported financial results for the quarter ended March 31, 2021.
United States United Kingdom British Columbia William Jarosz Venture Exchange The Satellos Bioscience Inc The Resulting Issuer
Source: finanznachrichten.de